X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (50341) 50341
Newsletter (5746) 5746
Newspaper Article (5466) 5466
Publication (3459) 3459
Book Review (693) 693
Magazine Article (466) 466
Trade Publication Article (312) 312
Book Chapter (286) 286
Web Resource (164) 164
Conference Proceeding (86) 86
Book / eBook (75) 75
Transcript (65) 65
Dissertation (45) 45
Reference (22) 22
Government Document (15) 15
Paper (11) 11
Data Set (6) 6
Streaming Video (4) 4
Report (2) 2
Journal / eJournal (1) 1
Presentation (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (37481) 37481
anticoagulants (32933) 32933
male (18033) 18033
index medicus (17849) 17849
female (17743) 17743
anticoagulants - therapeutic use (14569) 14569
middle aged (12003) 12003
aged (10502) 10502
thrombosis (9788) 9788
adult (9769) 9769
hematology (8843) 8843
anticoagulants - administration & dosage (7242) 7242
risk factors (6925) 6925
anticoagulants - adverse effects (6655) 6655
animals (6607) 6607
peripheral vascular disease (6315) 6315
research (5950) 5950
anticoagulants - pharmacology (5581) 5581
warfarin (5331) 5331
treatment outcome (5143) 5143
stroke (5098) 5098
heparin (5008) 5008
surgery (4849) 4849
thromboembolism (4615) 4615
care and treatment (4254) 4254
blood coagulation - drug effects (4176) 4176
cardiac & cardiovascular systems (4078) 4078
aged, 80 and over (3939) 3939
analysis (3713) 3713
glycosaminoglycans (3593) 3593
patients (3592) 3592
thrombin (3570) 3570
blood clot (3420) 3420
blood (3367) 3367
drug therapy (3347) 3347
time factors (3344) 3344
prevention (3328) 3328
atrial fibrillation (3254) 3254
retrospective studies (3076) 3076
anticoagulant (3052) 3052
health aspects (3038) 3038
medicine, general & internal (3022) 3022
anticoagulation (2998) 2998
coagulation (2951) 2951
medical research (2905) 2905
heparin - therapeutic use (2853) 2853
therapy (2836) 2836
risk (2829) 2829
mortality (2817) 2817
venous thromboembolism (2775) 2775
pharmacology & pharmacy (2734) 2734
administration, oral (2616) 2616
management (2538) 2538
adolescent (2519) 2519
prospective studies (2514) 2514
warfarin - therapeutic use (2509) 2509
hemorrhage - chemically induced (2414) 2414
medicine, experimental (2384) 2384
reports (2382) 2382
blood clots (2343) 2343
cardiac arrhythmia (2338) 2338
diagnosis (2301) 2301
blood coagulation (2291) 2291
international normalized ratio (2268) 2268
pregnancy (2255) 2255
hemorrhage (2178) 2178
medicine & public health (2171) 2171
blood coagulation tests (2170) 2170
abridged index medicus (2131) 2131
heparin - administration & dosage (2026) 2026
plasma (2022) 2022
molecular-weight heparin (2020) 2020
aspirin (2018) 2018
medicine (1985) 1985
venous thrombosis (1982) 1982
cardiology (1959) 1959
dose-response relationship, drug (1937) 1937
studies (1921) 1921
heparin - adverse effects (1880) 1880
dosage and administration (1868) 1868
proteins (1829) 1829
prothrombin time (1820) 1820
warfarin - administration & dosage (1786) 1786
partial thromboplastin time (1769) 1769
follow-up studies (1766) 1766
heparin - pharmacology (1763) 1763
usage (1756) 1756
warfarin - adverse effects (1700) 1700
clinical trials (1687) 1687
risk assessment (1665) 1665
disease (1648) 1648
complications and side effects (1634) 1634
platelet aggregation inhibitors - therapeutic use (1623) 1623
thrombosis - prevention & control (1612) 1612
thrombosis - etiology (1604) 1604
atrial fibrillation - drug therapy (1600) 1600
rats (1600) 1600
blood platelets (1584) 1584
deep-vein thrombosis (1570) 1570
rivaroxaban (1550) 1550
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (37) 37
Online Resources - Online (24) 24
Collection Dvlpm't (Acquisitions) - Vendor file (6) 6
Collection Dvlpm't (Acquisitions) - Closed Orders (3) 3
Scarborough Hospital - Online (2) 2
Chemistry (A D Allen) - Stacks (1) 1
Gerstein Science - May be requested in 6-10 wks (1) 1
Mt Sinai Hospital - Online (1) 1
Scarborough Hospital - General (1) 1
Scarborough Hospital - Hospital Department (1) 1
St. Michael's Hospital - Online (1) 1
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (58502) 58502
German (1184) 1184
French (800) 800
Russian (635) 635
Japanese (344) 344
Spanish (331) 331
Italian (267) 267
Chinese (203) 203
Polish (107) 107
Dutch (73) 73
Portuguese (60) 60
Czech (51) 51
Hungarian (41) 41
Turkish (40) 40
Danish (34) 34
Korean (32) 32
Norwegian (31) 31
Swedish (29) 29
Ukrainian (28) 28
Romanian (23) 23
Bulgarian (17) 17
Finnish (15) 15
Croatian (12) 12
Hebrew (11) 11
Serbian (6) 6
Arabic (4) 4
Icelandic (4) 4
Lithuanian (4) 4
Slovak (2) 2
Bosnian (1) 1
Greek (1) 1
Persian (1) 1
Urdu (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


2009, 1, ISBN 9781405168038, xii, 215
"Over the last decades, major progress has been made in quality assurance of hemostatic laboratory assays. This book will be an indispensable part of every... 
Thrombophilia | Anticoagulants | Hemostasis | Hemostatic Techniques | Clinical Laboratory Techniques | Blood Coagulation Disorders, Inherited | Analysis | Blood Coagulation Factors | Diagnosis | Thrombosis | Blood coagulation disorders | Blood | Laboratory manuals
Book
Journal Article
American Journal of Obstetrics and Gynecology, ISSN 0002-9378, 2016, Volume 214, Issue 1, pp. 108.e1 - 108.e14
Background Over 20% of pregnancies in patients with systemic lupus erythematosus (SLE) and/or antiphospholipid antibodies (APL) result in an adverse pregnancy... 
Obstetrics and Gynecology | angiogenic factors | systemic lupus erythematosus | preeclampsia | placental insufficiency | antiphospholipid antibodies | SOLUBLE ENDOGLIN | ALPHA | CLASSIFICATION | DEVELOP PREECLAMPSIA | ERYTHEMATOSUS | OBSTETRICS & GYNECOLOGY | HUMAN CYTOTROPHOBLASTS | FETAL-GROWTH RESTRICTION | TYROSINE KINASE-1 | DYSREGULATION | COHORT | Predictive Value of Tests | Pregnancy Trimester, First - blood | Antibodies, Antiphospholipid - blood | Prospective Studies | Humans | Heparin - therapeutic use | Lupus Erythematosus, Systemic - blood | Young Adult | Endoglin | Pregnancy Proteins - blood | Pregnancy, High-Risk | Lupus Erythematosus, Systemic - drug therapy | Adult | Female | Aspirin - therapeutic use | Pregnancy Trimester, Second - blood | Antiphospholipid Syndrome - blood | Fetal Growth Retardation - blood | Severity of Illness Index | Antiphospholipid Syndrome - drug therapy | Anticoagulants - therapeutic use | Receptors, Cell Surface - blood | Biomarkers - blood | Gestational Age | Pregnancy | Antigens, CD - blood | Anti-Inflammatory Agents, Non-Steroidal - therapeutic use | Pre-Eclampsia - blood | Placenta Growth Factor | Vascular Endothelial Growth Factor Receptor-1 - blood | Pregnancy Outcome | Lupus | Prognosis | Systemic lupus erythematosus | Pregnant women | Growth | Patient outcomes | Analysis | Fetus | Antiphospholipid antibodies | Angiogenic factors
Journal Article
Journal of Thrombosis and Haemostasis, ISSN 1538-7933, 11/2015, Volume 13, Issue 11, pp. 1960 - 1967
Derangement of the coagulation system is a common phenomenon in critically ill patients, who may present with severe bleeding and/or conditions associated with... 
critical care | thrombosis | point‐of‐care systems | platelet aggregation inhibitors | thoracic surgery | hemorrhage | Critical care | Point-of-care systems | Platelet aggregation inhibitors | Thoracic surgery | Hemorrhage | Thrombosis | THROMBELASTOGRAPHY | THROMBOELASTOGRAPHY | REACTIVITY | POSTPARTUM HEMORRHAGE | TRAUMATIC COAGULOPATHY | INTENSIVE-CARE | PLATELET-FUNCTION TESTS | STENT IMPLANTATION | TRANSFUSION | CARDIAC-SURGERY | PERIPHERAL VASCULAR DISEASE | point-of-care systems | HEMATOLOGY | Critical Care - methods | Point-of-Care Systems - economics | Humans | Critical Illness | Critical Care - economics | Drug Monitoring - methods | Postoperative Hemorrhage - blood | Blood Loss, Surgical | Blood Transfusion | Wounds and Injuries - therapy | Blood Coagulation Tests - economics | Thrombelastography - economics | Hemorrhage - etiology | Platelet Function Tests | Blood Coagulation Tests - methods | Postoperative Hemorrhage - therapy | Hemorrhage - therapy | Wounds and Injuries - blood | Blood Coagulation Disorders - etiology | Wounds and Injuries - complications | Anticoagulants - therapeutic use | Hemorrhage - blood | Anticoagulants - adverse effects | Anticoagulants - blood | Randomized Controlled Trials as Topic | Cost-Benefit Analysis | Blood Coagulation Disorders - blood | Blood Coagulation Disorders - diagnosis | Disease Management | Hemorrhage - chemically induced | Biological products | Medical examination | Health aspects | Blood | Acute coronary syndromes | Mortality | Coagulation
Journal Article
BRITISH JOURNAL OF HAEMATOLOGY, ISSN 0007-1048, 12/2013, Volume 163, Issue 5, pp. 666 - 673
There is increasing recognition that thrombotic complications may occur in patients with cirrhosis, and literature on antithrombotic treatment in these... 
anticoagulants | antithrombin | coagulation | anti‐Xa assay | cirrhosis | Anti-Xa assay | Anticoagulants | Cirrhosis | Antithrombin | Coagulation | anti-Xa assay | THROMBOSIS | MOLECULAR-WEIGHT HEPARIN | LIVER-DISEASE | HEMATOLOGY | HEMOSTASIS | Thiophenes - therapeutic use | Heparin, Low-Molecular-Weight - pharmacology | Polysaccharides - blood | Factor Xa Inhibitors | beta-Alanine - blood | Humans | Middle Aged | Heparin - therapeutic use | Male | Dabigatran | Drug Monitoring - methods | Morpholines - blood | Heparin, Low-Molecular-Weight - therapeutic use | Thiophenes - blood | Thrombophilia - etiology | Antithrombins - pharmacology | Rivaroxaban | Heparin, Low-Molecular-Weight - blood | Sensitivity and Specificity | beta-Alanine - pharmacology | Prothrombin - antagonists & inhibitors | Female | beta-Alanine - analogs & derivatives | Benzimidazoles - blood | Heparin - pharmacology | Morpholines - therapeutic use | Benzimidazoles - therapeutic use | Polysaccharides - therapeutic use | Liver Cirrhosis - drug therapy | Liver Cirrhosis - complications | beta-Alanine - therapeutic use | False Negative Reactions | Morpholines - pharmacology | Thiophenes - pharmacology | Liver Cirrhosis - blood | Polysaccharides - pharmacology | Anticoagulants - blood | Diagnostic Tests, Routine | Blood Coagulation - drug effects | Thrombophilia - blood | Anticoagulants - pharmacology | Antithrombins - blood | Blood Coagulation Tests | Heparin - blood | Benzimidazoles - pharmacology | Liver cirrhosis | Anticoagulants (Medicine)
Journal Article
PLoS ONE, ISSN 1932-6203, 06/2018, Volume 13, Issue 6, p. e0199204
Journal Article
JAMA, ISSN 0098-7484, 12/2013, Volume 310, Issue 23, pp. 2579 - 2579
Blood clots can cause problems when they prevent blood from flowing freely, especially to the heart and brain. Sometimes a doctor may not want a patient's... 
Blood vessels | Anticoagulants | Patient education | Medical treatment | Blood clots
Journal Article
Arteriosclerosis, Thrombosis, and Vascular Biology, ISSN 1079-5642, 02/2005, Volume 25, Issue 2, pp. 287 - 294
Journal Article
Advanced Drug Delivery Reviews, ISSN 0169-409X, 05/2012, Volume 64, Issue 7, pp. 640 - 665
The blood–brain barrier (BBB) is a highly regulated and efficient barrier that provides a sanctuary to the brain. It is designed to regulate brain homeostasis... 
Nanoparticles | Drug delivery | Receptor-mediated transport | Liposomes | Pathological conditions | Cell-mediated transport | Blood–brain barrier | Blood-brain barrier | HUMAN INSULIN-RECEPTOR | PROTEIN-KINASE-C | MICROVESSEL ENDOTHELIAL-CELLS | FOCAL CEREBRAL-ISCHEMIA | CELL-PENETRATING PEPTIDES | NECROSIS-FACTOR-ALPHA | PLURONIC BLOCK-COPOLYMERS | IMMUNODEFICIENCY-VIRUS TYPE-1 | PHARMACOLOGY & PHARMACY | CENTRAL-NERVOUS-SYSTEM | TIGHT JUNCTION PERMEABILITY | Brain - drug effects | Brain - metabolism | Pharmaceutical Preparations - metabolism | Animals | Biological Transport, Active - physiology | Biological Transport, Active - drug effects | Humans | Drug Delivery Systems - trends | Pharmaceutical Preparations - administration & dosage | Blood-Brain Barrier - drug effects | Drug Delivery Systems - methods | Blood-Brain Barrier - metabolism | Drugs | Multiple sclerosis | Transferrin | Drug delivery systems | Glycosaminoglycans | Endothelial growth factors | Peptides | Tissue plasminogen activator | Immunoglobulin G | Low density lipoproteins | Lactoferrins | Anticoagulants (Medicine) | Biological response modifiers | Drug resistance | Muscle proteins | HIV (Viruses) | Polyols | Vehicles | Epidermal growth factor | Polyethylene glycol | Myosin | Protein kinases | Alzheimer's disease | Vascular endothelial growth factor | Adenosine triphosphate | Asylum, Right of | Tyrosine | Nitrogen oxide | Immunoglobulins | Albumin | Heat shock proteins | Apolipoproteins | Endothelium | Propylene | Cogeneration power plants | Analysis | Nitric oxide | Monoclonal antibodies | Ethylene oxide | Adenylic acid | Mitogens | Methods | Nanotechnology
Journal Article